drugset / Trial / NCT04080596

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

NCT04080596

Phase 1 Completed 18 enrolled Hua Medicine Limited
SequentialOpen-labelTreatment

Summary

The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin.

Timeline

Start
2017-10-13
Primary completion
2017-12-05
Completion
2017-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dorzagliatin Small molecule

Indications

No indication recorded.